{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:00:00Z","timestamp":1785214800526,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Nicotinamide phosphoribosyltransferase (NAMPT) is a key immune-metabolic regulator linking nicotinamide adenine dinucleotide (NAD) salvage, inflammatory signaling, and tissue stress responses, but whether it occupies comparable transcriptomic contexts in osteoarthritic synovium and skeletal muscle remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective multi-cohort transcriptomic analysis using public GEO datasets with separate discovery and external supporting analysis stages. Discovery analyses included knee osteoarthritis synovium cohorts GSE55235 and GSE55457 and aging-related skeletal muscle proxy cohorts GSE38718 and GSE25941. Muscle-side findings were interpreted with explicit separation between aging-related skeletal muscle proxy cohorts and the clinically phenotyped sarcopenia external-support cohort. NAMPT abundance was evaluated by differential expression analysis and effect-size synthesis, immune and metabolic pathway activity was quantified by single-sample gene set enrichment analysis, and disease-adjusted partial correlations were used to define discovery-stage association structure. External supporting analyses were then performed in GSE12021, GSE254682, and the clinically phenotyped sarcopenia cohort GSE111016 to assess whether the direction of NAMPT abundance differences was reproduced in independent disease-relevant cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across the discovery stage, NAMPT showed a downward abundance signal in both tissue contexts, although meta-analytic pooling in knee osteoarthritis synovium was limited by between-study heterogeneity. External datasets provided partial support for lower NAMPT expression in disease-relevant synovium in GSE12021 and in clinically phenotyped sarcopenia muscle in GSE111016, whereas GSE254682 showed the same direction without statistical significance. Discovery-stage disease-adjusted coupling analyses indicated that osteoarthritic synovium retained stronger NAMPT associations with inflammatory and glycolytic programs, whereas aging-related skeletal muscle proxy cohorts showed weaker immune coupling and a pattern more consistent with metabolic deficit. Cohort-stratified stability analyses suggested that these associations were directionally consistent in osteoarthritic synovium but weaker and more heterogeneous in the muscle proxy cohorts. A reduced external association analysis showed partial module-level consistency with this contrast, including preserved inflammatory linkage in GSE254682 and a more oxidative-phosphorylation-oriented pattern in GSE111016. Exploratory cohort-level separation analyses and therapeutic inference were retained as secondary analyses and were not interpreted as evidence of clinical utility or efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest reduced NAMPT abundance with partial external support together with observational discovery-stage evidence of tissue-dependent immune-metabolic association patterns, and they favor context-specific interpretation and targeted experimental follow-up rather than uniform extrapolation across tissues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1853301","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:50Z","timestamp":1785212750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["NAMPT shows tissue-dependent immune-metabolic associations in osteoarthritic synovium and aging-related skeletal muscle"],"prefix":"10.3389","volume":"13","author":[{"given":"Qianyu","family":"He","sequence":"first","affiliation":[{"name":"Wangjing Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikai","family":"Qin","sequence":"additional","affiliation":[{"name":"Wangjing Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Yu","sequence":"additional","affiliation":[{"name":"Wangjing Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jing","sequence":"additional","affiliation":[{"name":"Wangjing Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[{"name":"Wangjing Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing."},{"key":"B3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","article-title":"Global, regional and national burden of osteoarthritis 1990-\u22122017: a systematic analysis of the Global Burden of Disease Study 2017","volume":"79","author":"Safiri","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis","volume":"2","author":"Martel-Pelletier","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone."},{"key":"B6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13075-017-1229-9","article-title":"Synovitis in osteoarthritis: current understanding with therapeutic implications","volume":"19","author":"Mathiessen","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ageing\/afy106","article-title":"The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses","volume":"48","author":"Mayhew","year":"2019","journal-title":"Age Ageing."},{"key":"B10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00061.2017","article-title":"Sarcopenia: aging-related loss of muscle mass and function","volume":"99","author":"Larsson","year":"2019","journal-title":"Physiol Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.2147\/CIA.S89585","article-title":"Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70 years and older living in the community: results of the FORMoSA study","volume":"10","author":"Kemmler","year":"2015","journal-title":"Clin Interv Aging."},{"key":"B14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrrheum.2017.50","article-title":"The role of metabolism in the pathogenesis of osteoarthritis","volume":"13","author":"Mobasheri","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MCO.0b013e32834dd297","article-title":"Chronic low-grade inflammation and age-related sarcopenia","volume":"15","author":"Beyer","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science."},{"key":"B19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ Intermediates: the biology and therapeutic potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD+ homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"50754","DOI":"10.1074\/jbc.M408388200","article-title":"The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells","volume":"279","author":"Revollo","year":"2004","journal-title":"J Biol Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8303570","DOI":"10.1155\/2020\/8303570","article-title":"An Update on the emerging role of visfatin in the pathogenesis of osteoarthritis and pharmacological intervention","volume":"2020","author":"Han","year":"2020","journal-title":"Evid Based Complement Alternat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"36300","DOI":"10.1074\/jbc.M803196200","article-title":"Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase","volume":"283","author":"Dvir-Ginzberg","year":"2008","journal-title":"J Biol Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41420-025-02672-w","article-title":"Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1268756","DOI":"10.3389\/fimmu.2023.1268756","article-title":"Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker","volume":"14","author":"Semerena","year":"2023","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e14139","DOI":"10.14814\/phy2.14139","article-title":"Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle","volume":"7","author":"de Guia","year":"2019","journal-title":"Physiol Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1152\/ajpendo.00318.2009","article-title":"Skeletal muscle NAMPT is induced by exercise in humans","volume":"298","author":"Costford","year":"2010","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1464815","DOI":"10.3389\/fcell.2024.1464815","article-title":"Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"102106","DOI":"10.1016\/j.arr.2023.102106","article-title":"NAD+: An old but promising therapeutic agent for skeletal muscle ageing","volume":"92","author":"Xu","year":"2023","journal-title":"Ageing Res Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar4526","article-title":"Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation","volume":"16","author":"Woetzel","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/gerona\/glt015","article-title":"Microarray analysis reveals novel features of the muscle aging process in men and women","volume":"68","author":"Liu","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1152\/japplphysiol.00435.2011","article-title":"Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults","volume":"112","author":"Raue","year":"2012","journal-title":"J Appl Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","article-title":"framework for oligonucleotide microarray preprocessing","volume":"26","author":"Carvalho","year":"2010","journal-title":"Bioinformatics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health."},{"key":"B41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"key":"B42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics."},{"key":"B44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"B47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5351\/CSAM.2015.22.6.665","article-title":"ppcor: An R package for a fast calculation to semi-partial correlation coefficients","volume":"22","author":"Kim","year":"2015","journal-title":"Commun Stat Appl Methods."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics."},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics."},{"key":"B50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics."},{"key":"B51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13075-023-03110-x","article-title":"Cellular characterisation of advanced osteoarthritis knee synovium","volume":"25","author":"Mimpen","year":"2023","journal-title":"Arthritis Res Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s42003-025-08586-8","article-title":"A multi-tissue human knee single-cell atlas identifies that osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages","volume":"8","author":"Raut","year":"2025","journal-title":"Commun Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"eadf4590","DOI":"10.1126\/scitranslmed.adf4590","article-title":"Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology","volume":"16","author":"Tang","year":"2024","journal-title":"Sci Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2020.00358","volume":"10","author":"Audrito","year":"2020","journal-title":"Front Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.1038\/srep13135","article-title":"Unique toll-like receptor 4 activation by NAMPT\/PBEF induces NF\u03baB signaling and inflammatory lung injury","volume":"5","author":"Camp","year":"2015","journal-title":"Sci Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/ar4467","article-title":"Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis","volume":"16","author":"Laiguillon","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/art.39608","article-title":"Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes","volume":"68","author":"Garcia-Carbonell","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2015-208476","article-title":"Dysregulated bioenergetics: a key regulator of joint inflammation","volume":"75","author":"Biniecka","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 Dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","article-title":"Skeletal muscle energy metabolism during exercise","volume":"2","author":"Hargreaves","year":"2020","journal-title":"Nat Metab."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.aad5168","article-title":"Biosensor reveals multiple sources for mitochondrial NAD+","volume":"352","author":"Cambronne","year":"2016","journal-title":"Science."},{"key":"B64","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00125-019-4831-3","article-title":"NAD+ metabolism as a target for metabolic health: have we found the silver bullet?","volume":"62","author":"Connell","year":"2019","journal-title":"Diabetologia."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cells8091047","article-title":"The role of PARPs in inflammation-and metabolic-related diseases: molecular mechanisms and beyond","volume":"8","author":"Ke","year":"2019","journal-title":"Cells."},{"key":"B66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cmet.2016.07.005","article-title":"Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle","volume":"24","author":"Frederick","year":"2016","journal-title":"Cell Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","article-title":"NAD+ metabolism, stemness, the immune response, and cancer","volume":"6","author":"Navas","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"117595","DOI":"10.1016\/j.bmc.2024.117595","article-title":"Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): updated progress and perspectives","volume":"99","author":"Wen","year":"2024","journal-title":"Bioorg Med Chem."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1853301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:53Z","timestamp":1785212753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1853301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":68,"alternative-id":["10.3389\/fmed.2026.1853301"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1853301","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1853301"}}